Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Aug. 23, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on August 17, 2017 , the Compensation Committee of the Board of Directors approved eleven equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to
View HTML
Toggle Summary CHF Solutions to Participate in the 6th Annual Intellisight Investor Conference on Tuesday, August 22, 2017
EDEN PRAIRIE, Minn. , Aug. 16, 2017 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS) announced today that John Erb , CEO, will be a featured presenter at the 6th Annual Intellisight Conference on Tuesday, August 22, 2017 from 3:35pm - 4:10pm central time in Minneapolis .
View HTML
Toggle Summary CHF Solutions, Inc. Announces 18% Revenue Growth for its Second Quarter and Provides Company Update
EDEN PRAIRIE, Minn. , Aug. 08, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today its second quarter results for the period ending June 30, 2017 , which included the following highlights: Revenue for second quarter ended June 30, 2017 increased 18% compared to the same
View HTML
Toggle Summary CHF Solutions Commences Manufacturing Transition of Aquadex FlexFlow® System to its Minnesota Facility
EDEN PRAIRIE, Minn. , Aug. 03, 2017 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS) announced today that it has begun the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc.
View HTML
Toggle Summary CHF Solutions, Inc. to Announce Second Quarter 2017 Results on August 8, 2017
EDEN PRAIRIE, Minn. , Aug. 01, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that its second quarter 2017 results will be released on Tuesday, August 8, 2017 , before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , July 28, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on July 25, 2017 , the Compensation Committee of the Board of Directors approved two equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to two
View HTML
Toggle Summary CHF Solutions Retains Laurent Duhoux as International Business Development Consultant to Expand International Markets for Aquadex Flexflow® System
EDEN PRAIRIE, Minn. , July 11, 2017 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS) announced today that Laurent Duhoux joined the Company as International Business Development consultant. In this capacity, Mr. Duhoux will be responsible for European and Asian market expansion for the
View HTML
Toggle Summary CHF Solutions' Aquadex FlexFlow® Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric Use
EDEN PRAIRIE, Minn. , June 29, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. , (fka Sunshine Heart, Inc. ) (NASDAQ:CHFS) announced today that researchers in the Stanford University School of Medicine's Department of Pediatrics have received FDA Investigational Device Exemption (IDE) approval to
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , June 06, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 25, 2017 , the independent directors approved two equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to two individuals entering into
View HTML
Toggle Summary CHF Solutions' Aquadex Flexflow® Ultrafiltration System Featured in the May 2017 Journal of The American College of Cardiology Review of Ultrafiltration as a Promising Treatment for Fluid Overload Associated with Heart Failure
EDEN PRAIRIE, Minn. , June 05, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. , (fka Sunshine Heart, Inc. ) (NASDAQ:CHFS) announced today that clinical trials using its Aquadex FlexFlow® Ultrafiltration System are featured in the May 2017 Journal of the American College of Cardiology (JACC) Treatment
View HTML